Brief: Vallon Pharmaceuticals Announces Stockholder Approval Of Merger With Gri Bio And Reverse Stock Split
April 20 (Reuters) - Vallon Pharmaceuticals Inc
VLON.O :
* VALLON PHARMACEUTICALS ANNOUNCES STOCKHOLDER APPROVAL OF
MERGER
WITH GRI BIO, INC. AND REVERSE STOCK SPLIT
* VALLON'S BOARD OF DIRECTORS HAS SET REVERSE SPLIT RATIO AT
1-FOR-30
Source text for Eikon: ID:nGNX801F8Q
Further company coverage: VLON.O
((reuters.briefs@thomsonreuters.com;))
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027